XNYS
RGA
Market cap16bUSD
Oct 08, Last price
255.93USD
1D
1.75%
1Q
10.72%
Jan 2017
103.39%
Name
Reinsurance Group of America Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Reinsurance Group of America, Inc. functions as a holding company, concentrating on both conventional and cutting-edge life and health reinsurance offerings. Its operations are structured across five primary segments: the U.S. and Latin America, Canada, Europe, the Middle East and Africa (EMEA), Asia Pacific, and a distinct Corporate and Other division. The U.S. and Latin America segment is responsible for marketing individual and group life and health reinsurance to clients within its region, employing various agreement types such as yearly renewable term, coinsurance, and modified coinsurance. In Canada, the company's focus is on individual life reinsurance, supplemented by a lesser extent of creditor, group life and health, critical illness, and disability reinsurance, generally through yearly renewable term and coinsurance contracts. The EMEA segment provides individual and group life and health products, including critical illness coverage—which offers a benefit upon the diagnosis of a specified illness—and underwritten annuities, typically facilitated via yearly renewable term and coinsurance agreements. The Asia Pacific segment covers individual and group life and health reinsurance, critical illness coverage, disability, and superannuation, predominantly structured with yearly renewable term and coinsurance agreements. Finally, the Corporate and Other segment encompasses investment income from unallocated assets, investment-related gains and losses, and service fee revenues. Founded in 1973, the company's corporate headquarters are situated in Chesterfield, Missouri.
Related entities
Subsidiaries (25)
RGA Life Reinsurance Company of Canada
RGA REINSURANCE COMPANY
RGA Reinsurance Company of Australia Limited
RGA UK Services Limited
TIMBERLAKE REINSURANCE COMPANY II
Key people
Kin Shun Cheng
President, Chief Executive Officer, Director · since 2024
Ray Kleeman
Chief Human Resources Officer, Executive Vice President · since 2022
Axel Andre
Chief Financial Officer, Executive Vice President · since 2024
Mark Brooks
Executive Vice President, Chief Information Officer · since 2023
Ronald Herrmann
Executive Vice President, Head of Americas for RGA Reinsurance Company · since 2024
William Hutton
Executive Vice President, General Counsel, Secretary · since 2011
Arthur Ozeki
Executive Vice President, Head of Asia Pacific · since 2021
Jonathan Porter
Executive Vice President, Global Chief Risk Officer · since 2016
Simon Wainwright
Executive Vice President, Head - Europe Middle East & Africa (EMEA) · since 2023
John Hayden
Executive Vice President, Controller
Pina Albo
Independent Director · since 2019
Michele Bang
Independent Director · since 2023
Independent Director · since 2018
Independent Director · since 2016
Independent Director · since 2018
Stephen O'Hearn
Non-Executive Independent Chairman of the Board · since 2023
Independent Director · since 2024
Shundrawn Thomas
Independent Director · since 2021
Independent Director · since 2022
Independent Director · since 2019
Legal address
C/O C T Corporation System
5661 Telegraph Rd Ste 4B
Saint Louis, MO 63129-4275
US
5661 Telegraph Rd Ste 4B
Saint Louis, MO 63129-4275
US
Headquarters
16600 SWINGLEY RIDGE RD
CHESTERFIELD, MO 63017-1706
US
CHESTERFIELD, MO 63017-1706
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||